Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 35 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

7 trials in Phase 3/4

Results Transparency

23%

7 of 30 completed trials have results

Key Signals

1 recruiting7 with results

Enrollment Performance

Analytics

Phase 2

10(32.3%)

N/A

8(25.8%)

Phase 1

5(16.1%)

Phase 4

4(12.9%)

Phase 3

3(9.7%)

Early Phase 1

1(3.2%)

31Total

Phase 2(10)

N/A(8)

Phase 1(5)

Phase 4(4)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials

NCT07508189Not ApplicableActive Not Recruiting

Communication Intervention to Improve Influenza Vaccination Rates Among Elderly in Can Tho

Role: collaborator

NCT04830800Phase 1Completed

A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1)

Role: collaborator

NCT05940194Phase 2Completed

NDV-HXP-S Vaccine Clinical Trial (COVIVAC)

Role: collaborator

NCT06681636Phase 2Not Yet Recruiting

Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure

Role: lead

NCT04516954Early Phase 1Completed

Convalescent Plasma for COVID-19 Patients

Role: collaborator

NCT04521036Phase 1Completed

Convalescent Plasma for COVID-19 Patients (CPCP)

Role: collaborator

NCT02961231Phase 4Completed

Evaluation of PCV Schedules in a Naive Population in Vietnam

Role: collaborator

NCT05506475Not Yet Recruiting

Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam

Role: collaborator

NCT04794725Not ApplicableCompleted

MOVIDA 1 Ter - Evaluation of the Cobas® Plasma Separation Card in the Field in Vietnam

Role: collaborator

NCT05142514Phase 2Completed

Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)

Role: collaborator

NCT04590521Phase 4Completed

HPV Vaccine Immunity in High-risk Women

Role: collaborator

NCT04358289Not ApplicableRecruiting

Generating Collective Solutions to Reduce Unnecessary Antibiotic Use in Vietnam

Role: collaborator

NCT04798534Not ApplicableCompleted

Intervention to Facilitate MMT/HIV Service Decentralization in Vietnam

Role: collaborator

NCT03249493Completed

Monitoring Of Viral Load In Decentralised Area in Vietnam

Role: collaborator

NCT03670251Not ApplicableCompleted

Evaluation of Hepatitis C Viral Load Quantification on DBS in Vietnam

Role: collaborator

NCT02492165Phase 3Completed

Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects

Role: collaborator

NCT03703336Phase 3Completed

Phase III Study of Liquid Formulation of ROTAVIN

Role: collaborator

NCT03293355Not ApplicableCompleted

Multilevel Integration Strategies to Enhance Service Provider Networks in Vietnam

Role: collaborator

NCT01698346Phase 4Completed

Pertussis (Tdap) Vaccination in Pregnancy

Role: collaborator

NCT04089436Unknown

SouthEast Asia Encephalitis Project

Role: collaborator